CAMBRIDGE, Mass., June 11, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of James R. Sulat, Chief Financial Officer and Director of Memory Pharmaceuticals Corp., to its Board of Directors effective June 5, 2008.
